Back to Search
Start Over
Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer.
- Source :
- Cell Death & Disease; Jun2019, Vol. 10 Issue 6, pN.PAG-N.PAG, 1p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 20414889
- Volume :
- 10
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- Cell Death & Disease
- Publication Type :
- Academic Journal
- Accession number :
- 137251784
- Full Text :
- https://doi.org/10.1038/s41419-019-1597-y